PATENT CLAIM ANALYSIS

Application Number: 15986215
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-01
Patent Classification: ["514", "226500"]

Abstract:
Disclosed herein are compositions comprising an NSAID such as meloxicam in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of conditions such as pain.

Claim (Index 2):
The method of  claim 1 , wherein the solid dosage form contains about 10 mg to about 20 mg of meloxicam.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.35135
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15902770', '15797955', '15132130', '15984055', '15936176']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8357804435149452
- 35 USC 102 Novelty (BERT): 0.5585885363295205
- Combined Prediction Score: 0.8080612527964027
- Mean Citation Score: 396.446106
- Max Citation Score: 430.14255
- Similarity Product: 427.63651541418136

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test